D. Song

发表

Multiparameter comparative analysis reveals differential impacts of various cytokines on CART cell phenotype and function ex vivo and in vivo

D. Powell, Qunrui Ye, Yongmin Tang, 2016, Oncotarget.

In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB).

G. Coukos, D. Powell, C. June, 2011, Cancer research.

Effective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression level

D. Powell, Qunrui Ye, M. Figini, 2016, Journal of Hematology & Oncology.

Chimeric Antigen Receptor T Cells with Dissociated Signaling Domains Exhibit Focused Antitumor Activity with Reduced Potential for Toxicity In Vivo

Raphael Sandaltzopoulos, D. Powell, C. June, 2013, Cancer Immunology Research.

Clinical study of docetaxel-vinorelbine as second-line chemotherapy in advanced non-small cell lung cancer

Zhehai Wang, Jun Guo, Jie Liu, 2008 .

CD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in Tumor

G. Coukos, D. Powell, Chunsheng Li, 2013, Clinical Cancer Research.

Control of triple-negative breast cancer using ex vivo self-enriched, costimulated NKG2D CAR T cells

D. Powell, D. Song, Yali Han, 2018, Journal of Hematology & Oncology.

Pro-survival signaling via CD27 costimulation drives effective CAR T-cell therapy

D. Powell, D. Song, 2012, Oncoimmunology.

© 2012 Landes Bioscience. Do not distribute. Pro-survival signaling via CD27 costimulation drives effective CAR T-cell therapy

D. Powell, D. Song, 2012 .

CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia

M. Carroll, D. Porter, C. June, 2015, Leukemia.

A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity

D. Powell, Qunrui Ye, M. Figini, 2015, Oncotarget.

Primary Human Ovarian Epithelial Cancer Cells Broadly Express HER2 at Immunologically-Detectable Levels

G. Coukos, D. Powell, R. Sandaltzopoulos, 2012, PloS one.

Rigorous optimization and validation of potent RNA CAR T cell therapy for the treatment of common epithelial cancers expressing folate receptor

D. Powell, Rachel C. Lynn, Yangbing Zhao, 2015, Oncotarget.

CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo.

D. Powell, Qunrui Ye, M. Figini, 2012, Blood.

Finding a needle in a haystack

Qunrui Ye, Qunrui Ye, De-Gang Song, 2013, Oncoimmunology.

Chimeric NKG2D CAR-expressing T cell-mediated attack of human ovarian cancer is enhanced by histone deacetylase inhibition.

D. Powell, Stephen P. Santoro, Qunrui Ye, 2013, Human gene therapy.

CD 27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo

D. Powell, Qunrui Ye, M. Figini, 2012 .

The genetic polymorphisms of intercellular cell adhesion molecules and breast cancer susceptibility: a meta-analysis

Zhehai Wang, Meili Sun, D. Song, 2013, Molecular Biology Reports.

A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity

Qunrui Ye, M. Figini, M. Poussin, 2015, OncoTarget.

CD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in Tumor

G. Coukos, Chunsheng Li, Qunrui Ye, 2013, Clinical Cancer Research.